Elucidation of lipid nanoparticle surface structure in mRNA vaccines
Mingzhang Maple Wang1, Caitlin N Wappelhorst2, Erika L Jensen2
1Analytical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc., 875 Chesterfield Parkway West, Chesterfield, MO, 63017, USA. mingzhang.wang@pfizer.com.
Abstract:
Lipid nanoparticles (LNPs) have been used as a carrier for messenger RNA (mRNA) vaccines. Surface properties of LNPs are important to the stability and function of mRNA vaccines. Polyethylene-glycol (PEG) is a functional lipid at the surface of LNPs that improves colloidal stability, increases circulation time, and impacts cellular uptake. In this study, we explore in-depth lipid composition at the surface of mRNA-LNPs using high-field nuclear magnetic resonance (NMR) spectroscopy. Our results provide a unique surface lipid profile of intact LNPs identifying PEG chains and partial ionizable lipids are present with quantification capability. The surface PEG density is determined to reveal the brush-like conformation on the surface of mRNA-LNPs. Furthermore, we implement a diffusion NMR strategy for routine testing of formulated drug products during drug development. Comparative NMR analysis of different vaccine preparations and stability samples provides a global view of the mRNA-LNP surface structure for enhanced product knowledge.


